These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6058731)

  • 1. Interference of lysogenic Shigella flexneri with antimicrobial disc susceptibility readings.
    Williams RB
    Am J Med Technol; 1967; 33(4):337-8. PubMed ID: 6058731
    [No Abstract]   [Full Text] [Related]  

  • 2. [Susceptibility of shigellae to antibiotics, chemotherapy and bacteriophage].
    da Costa Val JA; de Melo SM; Ferreira M das D
    Hospital (Rio J); 1965 Apr; 67(4):833-8. PubMed ID: 5294230
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug resistance factor-R].
    Mitsuhashi S
    Tanpakushitsu Kakusan Koso; 1968 Jun; 13(7):643-50 contd. PubMed ID: 4882141
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistance of Shigella flexneri to antibiotics.
    Slopek S; Tkaczowa A; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1968; 16(3):354-8. PubMed ID: 5666680
    [No Abstract]   [Full Text] [Related]  

  • 5. On lactosepositive variants of Sh. flexneri 2a and serotype 145-46.
    Trifonova A; Tekelieva R
    Zentralbl Bakteriol Orig; 1969 Jan; 209(2):196-203. PubMed ID: 5386532
    [No Abstract]   [Full Text] [Related]  

  • 6. Serodiversity and antimicrobial resistance pattern of Shigella isolates at Gondar University teaching hospital, Northwest Ethiopia.
    Tiruneh M
    Jpn J Infect Dis; 2009 Mar; 62(2):93-7. PubMed ID: 19305047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shigella isolates of Nepal: changes in the incidence of shigella subgroups and trends of antimicrobial susceptibility pattern.
    Kansakar P; Malla S; Ghimire GR
    Kathmandu Univ Med J (KUMJ); 2007; 5(1):32-7. PubMed ID: 18603983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The adaptation of therapeutic standards as a function of antibiotic sensitivity of strains of Shigella spp. isolated in Rwanda in 1997].
    Aldighieri S; Kamoso P; Suermondt G; Rugimbanya P; Ngabonziza C; Kayirangwa E
    Med Trop (Mars); 1997; 57(4):412. PubMed ID: 9612786
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sensitivity to antibacterial preparations of the causative agents of intestinal infections in Transcarpathia. II. Shigella and enteropathogenic Escherichia].
    Grishchenko RI; Sakal' NN; Drozd SI; Kishko AM
    Mikrobiol Zh (1978); 1980; 42(1):91-7. PubMed ID: 6988685
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial resistances among Shigella in New Zealand.
    Brett MS
    N Z Med J; 1998 Jun; 111(1068):234-5. PubMed ID: 9695753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of resistance to antibiotics and phages in sonne dysentery bacteria under the influence of streptomycin in combination with vitamin B 12].
    Dziubak ST
    Antibiotiki; 1965 Sep; 10(9):837-40. PubMed ID: 5872782
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial susceptibility of Shigella isolates in eight Asian countries, 2001-2004.
    Kuo CY; Su LH; Perera J; Carlos C; Tan BH; Kumarasinghe G; So T; Van PH; Chongthaleong A; Song JH; Chiu CH
    J Microbiol Immunol Infect; 2008 Apr; 41(2):107-11. PubMed ID: 18473096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The comparative aspects of the behavior of antimicrobial agents against 1299 Shigella strains isolated in the years 1977, 1986 and 1995].
    Lucinescu S; Lucinescu AM
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):39-44. PubMed ID: 9235142
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence and antimicrobial susceptibility patterns of Shigella species in Asmara, Eritrea, northeast Africa.
    Naik DG
    J Microbiol Immunol Infect; 2006 Oct; 39(5):392-5. PubMed ID: 17066201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance in Shigella species isolated in Dakar, Senegal (2004-2006).
    Sire JM; Macondo EA; Perrier-Gros-Claude JD; Siby T; Bahsoun I; Seck A; Garin B
    Jpn J Infect Dis; 2008 Jul; 61(4):307-9. PubMed ID: 18653976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotic resistance of Shigella strains isolated in Cádiz (author's transl)].
    García Martos P; Marín Casanova P; García Herruzo J; Fernández Gutiérrez del Alamo C
    Med Clin (Barc); 1980 Dec; 75(10):425-9. PubMed ID: 7464328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The susceptibility of 44 strains of Shigellae to eleven anti-microbial agents.
    Sng EH; Lam S
    Singapore Med J; 1970 Sep; 11(3):162-5. PubMed ID: 5472057
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serotype distribution and antimicrobial resistance rates of Shigella spp. isolates in Tehran, Iran].
    Salmanzadeh-Ahrabi S; Jafari F; Habibi E; Irajian GR; Aslani MM; Baghbani-Arani F; Zali MR
    Mikrobiyol Bul; 2007 Jul; 41(3):453-7. PubMed ID: 17933258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of Shigella susceptibility to commonly used antimicrobials in the Temuco Regional Hospital, Chile 1990 - 2001].
    Boehme C; Iglesias T; Loyola A; Soto L; Rodríguez G; Reydet P; Illesca V
    Rev Med Chil; 2002 Sep; 130(9):1021-6. PubMed ID: 12434650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple drug resistance within Shigella serogroups.
    Gebre-Yohannes A; Limenih Y
    Ethiop Med J; 1980 Jan; 18(1):7-14. PubMed ID: 7379780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.